Pranger AD - Search Results

1

Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approach.

Pranger AD, Alffenaar JW, Aarnoutse RE. Pranger AD, et al. Curr Pharm Des. 2011;17(27):2900-30. doi: 10.2174/138161211797470200. Curr Pharm Des. 2011. PMID: 21834759 Review.

2

Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience.

Pranger AD, van Altena R, Aarnoutse RE, van Soolingen D, Uges DR, Kosterink JG, van der Werf TS, Alffenaar JW. Pranger AD, et al. Eur Respir J. 2011 Oct;38(4):888-94. doi: 10.1183/09031936.00176610. Epub 2011 Feb 10. Eur Respir J. 2011. PMID: 21310881 Free article.

3

The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019.

Pranger AD, van der Werf TS, Kosterink JGW, Alffenaar JWC. Pranger AD, et al. Drugs. 2019 Feb;79(2):161-171. doi: 10.1007/s40265-018-1043-y. Drugs. 2019. PMID: 30617959 Free PMC article. Review.

4

Limited-sampling strategies for therapeutic drug monitoring of moxifloxacin in patients with tuberculosis.

Pranger AD, Kosterink JG, van Altena R, Aarnoutse RE, van der Werf TS, Uges DR, Alffenaar JW. Pranger AD, et al. Ther Drug Monit. 2011 Jun;33(3):350-4. doi: 10.1097/FTD.0b013e31821b793c. Ther Drug Monit. 2011. PMID: 21544017

5

Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.

Alsaad N, van Altena R, Pranger AD, van Soolingen D, de Lange WC, van der Werf TS, Kosterink JG, Alffenaar JW. Alsaad N, et al. Among authors: pranger ad. Eur Respir J. 2013 Aug;42(2):504-12. doi: 10.1183/09031936.00114812. Epub 2012 Oct 25. Eur Respir J. 2013. PMID: 23100498 Free article.

6

Determination of moxifloxacin in human plasma, plasma ultrafiltrate, and cerebrospinal fluid by a rapid and simple liquid chromatography- tandem mass spectrometry method.

Pranger AD, Alffenaar JW, Wessels AM, Greijdanus B, Uges DR. Pranger AD, et al. J Anal Toxicol. 2010 Apr;34(3):135-41. doi: 10.1093/jat/34.3.135. J Anal Toxicol. 2010. PMID: 20406537

7

Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Bolhuis MS, Panday PN, Pranger AD, Kosterink JG, Alffenaar JW. Bolhuis MS, et al. Among authors: pranger ad. Pharmaceutics. 2011 Nov 18;3(4):865-913. doi: 10.3390/pharmaceutics3040865. Pharmaceutics. 2011. PMID: 24309312 Free PMC article.

8

Linezolid: safety and efficacy monitoring.

Bolhuis MS, Pranger AD, Alffenaar JW. Bolhuis MS, et al. Among authors: pranger ad. Eur Respir J. 2012 May;39(5):1275-6; author reply 1276-7. doi: 10.1183/09031936.00200911. Eur Respir J. 2012. PMID: 22547740 Free article. No abstract available.

9

Rifampicin and moxifloxacin for tuberculous meningitis.

Akkerman O, Pranger A, van Altena R, van der Werf T, Alffenaar JW. Akkerman O, et al. Lancet Infect Dis. 2013 Jul;13(7):568-9. doi: 10.1016/S1473-3099(13)70101-4. Lancet Infect Dis. 2013. PMID: 23809221 No abstract available.

10

Carbamazepine intervention in a patient with efavirenz-induced liver injury.

Jacobs TG, Burger DM, Pranger AD, Khoo SH, Drenth JPH, van Crevel R. Jacobs TG, et al. Among authors: pranger ad. AIDS. 2019 May 1;33(6):1097-1098. doi: 10.1097/QAD.0000000000002116. AIDS. 2019. PMID: 30946165 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page